Researchers in this study aimed to improve how breast cancer is detected and monitored using simple blood tests. One major challenge in cancer diagnostics is finding reliable biomarkers—measurable signals in the body that indicate the presence of disease. While proteins in blood are often studied, many important signals, such as phosphoproteins, are difficult to detect because they are unstable and easily broken down.
To overcome this, the researchers focused on extracellular vesicles (EVs)—tiny particles released by cells into the bloodstream. These vesicles act like protective containers, shielding their contents from damage. Because of this, EVs can preserve important molecular signals that might otherwise be lost.
Using advanced mass spectrometry techniques, the team analyzed EVs from blood samples of breast cancer patients and healthy individuals. They identified nearly 10,000 unique phosphopeptides and found that more than 100 phosphoproteins were significantly elevated in breast cancer patients.
The researchers also validated several of these markers in additional patient samples, demonstrating that EV phosphoproteins could serve as reliable indicators of disease. Overall, the study shows that analyzing protected molecules inside EVs may provide a powerful new approach for cancer detection.
